Ying-Sheng Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ying-Sheng Cheng has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Ke-Zhong Shang
Shanghai Tong Ji University
7 shared publicationsMing-Hua Li
Shanghai Tong Ji University
7 shared publicationsNi-Wei Chen
Department of Gastroenterology, The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China
7 shared publicationsQi-Xin Zhuang
6 shared publicationsWei-Xiong Chen
Shanghai Jiao Tong University
6 shared publicationsJun-Gong Zhao
Department of Diagnostic and Interventional Radiology, The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China
3 shared publications
Latest Publications
- 18 October 2013
- Published by Springer Nature in Current Hypertension Reports
- Vol. 15 (6) , 650-658
A GPS Map for Pulmonary Hypertension: A Review of Imaging Modalities
Pulmonary hypertension (PH) is a lethal disease with a prevalence of 10-20 % in the general population. The current gold standard diagnosis approach is right heart catheterization, directly detecting pulmonary artery pressure. Imaging for PH patients plays an important role in the etiological diagnosis and evaluation of right heart (RV) function, which is a key determinant of morbidity and mortality in PH patients. Currently, echocardiography is the first-line imaging modality for screening PH and evaluating RV function. CMRI is the gold standard method to evaluate RV function. MDCT, radionuclide ventriculography and pulmonary angiography are mostly used in the differential diagnosis of the cause of PH. In this review article, we also mention several newly studied imaging modalities, such as three-dimensional echocardiography, intravascular ultrasound (IVUS) and optical coherence tomography (OCT), which showed promise for early diagnosis of PH.
- 18 October 2013
- Published by Springer Nature in Current Hypertension Reports
- Vol. 15 (6) , 650-658
A GPS Map for Pulmonary Hypertension: A Review of Imaging Modalities
Pulmonary hypertension (PH) is a lethal disease with a prevalence of 10-20 % in the general population. The current gold standard diagnosis approach is right heart catheterization, directly detecting pulmonary artery pressure. Imaging for PH patients plays an important role in the etiological diagnosis and evaluation of right heart (RV) function, which is a key determinant of morbidity and mortality in PH patients. Currently, echocardiography is the first-line imaging modality for screening PH and evaluating RV function. CMRI is the gold standard method to evaluate RV function. MDCT, radionuclide ventriculography and pulmonary angiography are mostly used in the differential diagnosis of the cause of PH. In this review article, we also mention several newly studied imaging modalities, such as three-dimensional echocardiography, intravascular ultrasound (IVUS) and optical coherence tomography (OCT), which showed promise for early diagnosis of PH.
- 12 January 2012
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 125 (2) , 1302-1309
Synthesis and characterization of PEG‐graft‐quaternized chitosan and cationic polymeric liposomes for drug delivery
- 12 January 2012
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 125 (2) , 1302-1309
Synthesis and characterization of PEG‐graft‐quaternized chitosan and cationic polymeric liposomes for drug delivery
- 1 December 2010
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 195 (6) , 1429-1437
13-Year Follow-Up of a Prospective Comparison of the Long-Term Clinical Efficacy of Temporary Self-Expanding Metallic Stents and Pneumatic Dilatation for the Treatment of Achalasia in 120 Patients
OBJECTIVE. The purpose of this article is to compare the efficacy of self-expanding metallic stents and pneumatic dilation for the long-term clinical treatment of achalasia. SUBJECTS AND METHODS. Patients diagnosed with achalasia (n = 120) were allocated for treatment with pneumatic dilation (n = 30; group A) or a temporary self-expanding metallic stent with a diameter of 20 mm (n = 30; group B), 25 mm (n = 30; group C), or 30 mm (n = 30; group D). Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up was performed at 6 months and at 1, 3–5, 5–8, 8–10, and more than 10 years after surgery. RESULTS. Pneumatic dilation and stent placement were technically successful in all patients. The follow-up at more than 10 years revealed that the clinical remission rate in group D (83.3%) was higher than that in groups A (0%), B (0%), and C (28.6%), and the overall cumulative clinical failure rate in group D (13%) was lower than that in groups A (76.7%), B (53.3%), and C (26.7%). Patients in group D exhibited reduced dysphagia scores and lower esophageal sphincter pressures and had normal levels of barium height and width during the follow-up periods, whereas these markers increased with time in the other groups. The duration of primary patency in group D was also longer than that in groups A, B, and C. CONCLUSION. A temporary self-expanding metallic stent with a diameter of 30 mm has superior clinical efficacy for the treatment of achalasia compared with pneumatic dilation or self-expanding metallic stents with diameters of 20 or 25 mm.
- 1 December 2010
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 195 (6) , 1429-1437
13-Year Follow-Up of a Prospective Comparison of the Long-Term Clinical Efficacy of Temporary Self-Expanding Metallic Stents and Pneumatic Dilatation for the Treatment of Achalasia in 120 Patients
OBJECTIVE. The purpose of this article is to compare the efficacy of self-expanding metallic stents and pneumatic dilation for the long-term clinical treatment of achalasia. SUBJECTS AND METHODS. Patients diagnosed with achalasia (n = 120) were allocated for treatment with pneumatic dilation (n = 30; group A) or a temporary self-expanding metallic stent with a diameter of 20 mm (n = 30; group B), 25 mm (n = 30; group C), or 30 mm (n = 30; group D). Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up was performed at 6 months and at 1, 3–5, 5–8, 8–10, and more than 10 years after surgery. RESULTS. Pneumatic dilation and stent placement were technically successful in all patients. The follow-up at more than 10 years revealed that the clinical remission rate in group D (83.3%) was higher than that in groups A (0%), B (0%), and C (28.6%), and the overall cumulative clinical failure rate in group D (13%) was lower than that in groups A (76.7%), B (53.3%), and C (26.7%). Patients in group D exhibited reduced dysphagia scores and lower esophageal sphincter pressures and had normal levels of barium height and width during the follow-up periods, whereas these markers increased with time in the other groups. The duration of primary patency in group D was also longer than that in groups A, B, and C. CONCLUSION. A temporary self-expanding metallic stent with a diameter of 30 mm has superior clinical efficacy for the treatment of achalasia compared with pneumatic dilation or self-expanding metallic stents with diameters of 20 or 25 mm.
- 1 April 2010
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 23 (5) , 361-367
Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up
The present study compares the efficacy of a self-expanding metallic stent (SEMS, diameter of 30 mm) and pneumatic dilation for the long-term clinical treatment of achalasia. A total of 155 patients diagnosed with achalasia were allocated for pneumatic dilation (n= 80, group A) or a temporary, 30-mm diameter SEMS (n= 75, group B). The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4-5 days after placement. Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up observations were performed at 6 months and at 1, 3-5, 5-8, 8-10, and >10 years, postoperatively. Pneumatic dilation and stent placement were technically successful in all of the patients. There were no significant differences in technique success, 30-day mortality, or complications between the two groups. The clinical remission rate in group A was significantly lower than that in group B at 1, 1-3, 3-5, 5-8 and, >10 years (P < 0.05), while the cumulative clinical failure rate in group A (66%, 53/80) was higher than that in group B (92%, 6/75). The mean primary patency in group B was significantly longer than that in group A (4.2 vs 2.1 years, respectively; P < 0.001). A temporary, 30-mm diameter SEMS was associated with a better long-term clinical efficacy in the treatment of patients with achalasia as compared with treatment with pneumatic dilation.
- 1 April 2010
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 23 (5) , 361-367
Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up
The present study compares the efficacy of a self-expanding metallic stent (SEMS, diameter of 30 mm) and pneumatic dilation for the long-term clinical treatment of achalasia. A total of 155 patients diagnosed with achalasia were allocated for pneumatic dilation (n= 80, group A) or a temporary, 30-mm diameter SEMS (n= 75, group B). The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4-5 days after placement. Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up observations were performed at 6 months and at 1, 3-5, 5-8, 8-10, and >10 years, postoperatively. Pneumatic dilation and stent placement were technically successful in all of the patients. There were no significant differences in technique success, 30-day mortality, or complications between the two groups. The clinical remission rate in group A was significantly lower than that in group B at 1, 1-3, 3-5, 5-8 and, >10 years (P < 0.05), while the cumulative clinical failure rate in group A (66%, 53/80) was higher than that in group B (92%, 6/75). The mean primary patency in group B was significantly longer than that in group A (4.2 vs 2.1 years, respectively; P < 0.001). A temporary, 30-mm diameter SEMS was associated with a better long-term clinical efficacy in the treatment of patients with achalasia as compared with treatment with pneumatic dilation.
- Open Access
- 1 January 2010
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (40) , 5111-7
Temporary self-expanding metallic stents for achalasia: A prospective study with a long-term follow-up
To compare the efficacy of self-expanding metallic stents (SEMSs) for the long-term clinical treatment of achalasia. Ninety achalasic patients were treated with a temporary SEMS with a diameter of 20 mm (n = 30, group A), 25 mm (n = 30, group B) or 30 mm (n = 30, group C). Data on clinical symptoms, complications and treatment outcomes were collected, and follow-up was made at 6 mo and at 1, 3-5, 5-8, 8-10 and > 10 years, postoperatively. Stent placement was successful in all patients. Although chest pain occurrence was high, stent migration was less in group C than in groups A and B. The clinical remission rate at 5-8, 8-10 and > 10 years in group C was higher than that in the other two groups. The treatment failure rate was lower in group C (13%) than in groups A (53%) and B (27%). SEMSs in group C resulted in reduced dysphagia scores and lowered esophageal sphincter pressures, as well as normal levels of barium height and width during all the follow-up time periods. Conversely, these parameters increased over time in groups A and B. The primary patency in group C was longer than in groups A and B. A temporary SEMS with a diameter of 30 mm is associated with a superior long-term clinical efficacy in the treatment of achalasia compared with a SEMS with a diameter of 20 mm or 25 mm.
- 1 January 2010
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 16 (40) , 5111-7
Open AccessTemporary self-expanding metallic stents for achalasia: A prospective study with a long-term follow-up
To compare the efficacy of self-expanding metallic stents (SEMSs) for the long-term clinical treatment of achalasia. Ninety achalasic patients were treated with a temporary SEMS with a diameter of 20 mm (n = 30, group A), 25 mm (n = 30, group B) or 30 mm (n = 30, group C). Data on clinical symptoms, complications and treatment outcomes were collected, and follow-up was made at 6 mo and at 1, 3-5, 5-8, 8-10 and > 10 years, postoperatively. Stent placement was successful in all patients. Although chest pain occurrence was high, stent migration was less in group C than in groups A and B. The clinical remission rate at 5-8, 8-10 and > 10 years in group C was higher than that in the other two groups. The treatment failure rate was lower in group C (13%) than in groups A (53%) and B (27%). SEMSs in group C resulted in reduced dysphagia scores and lowered esophageal sphincter pressures, as well as normal levels of barium height and width during all the follow-up time periods. Conversely, these parameters increased over time in groups A and B. The primary patency in group C was longer than in groups A and B. A temporary SEMS with a diameter of 30 mm is associated with a superior long-term clinical efficacy in the treatment of achalasia compared with a SEMS with a diameter of 20 mm or 25 mm.
- Open Access
- 19 March 2009
- Published by Springer Nature in European Radiology
- Vol. 19 (8) , 1973-1980
Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience
To prospectively evaluate the long-term clinical safety and efficacy of a newly designed self-expanding metallic stent (SEMS) in the treatment of patients with achalasia. Seventy-five patients with achalasia were treated with a temporary SEMS with a 30-mm diameter. The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4–5 days after stent placement. Follow-up data focused on dysphagia score, technique and clinical success, clinical remissions and failures, and complications and was performed at 6 months, 1 year, and within 3 to 5 years, 5 to 8 years, 8 to 10 years, and >10 years postoperatively. Stent placement was technically successful in all patients. Complications included stent migration (n = 4, 5.33%), chest pain (n = 28, 38.7%), reflux (n = 15, 20%), and bleeding (n = 9, 12%). No perforation or 30-day mortality occurred. Clinical success was achieved in all patients 1 month after stent removal. The overall remission rates at 6 months, 1, 1–3, 3–5, 5–8, 8–10, and >10 year follow-up periods were 100%, 96%, 93.9%, 90.9%, 100%, 100%, and 83.3%, respectively. Stent treatment failed in six patients, and the overall remission rate in our series was 92%. The median and mean primary patencies were 2.8 ± 0.28 years (95% CI: 2.25–3.35) and 4.28 ± 0.40 years (95% CI: 3.51–5.05), respectively. The use of temporary SEMSs with 30-mm diameter proved to be a safe and effective approach for managing achalasia with a long-term satisfactory clinical remission rate.
- 19 March 2009
- Published by Springer Nature in European Radiology
- Vol. 19 (8) , 1973-1980
Open AccessLong-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience
To prospectively evaluate the long-term clinical safety and efficacy of a newly designed self-expanding metallic stent (SEMS) in the treatment of patients with achalasia. Seventy-five patients with achalasia were treated with a temporary SEMS with a 30-mm diameter. The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4–5 days after stent placement. Follow-up data focused on dysphagia score, technique and clinical success, clinical remissions and failures, and complications and was performed at 6 months, 1 year, and within 3 to 5 years, 5 to 8 years, 8 to 10 years, and >10 years postoperatively. Stent placement was technically successful in all patients. Complications included stent migration (n = 4, 5.33%), chest pain (n = 28, 38.7%), reflux (n = 15, 20%), and bleeding (n = 9, 12%). No perforation or 30-day mortality occurred. Clinical success was achieved in all patients 1 month after stent removal. The overall remission rates at 6 months, 1, 1–3, 3–5, 5–8, 8–10, and >10 year follow-up periods were 100%, 96%, 93.9%, 90.9%, 100%, 100%, and 83.3%, respectively. Stent treatment failed in six patients, and the overall remission rate in our series was 92%. The median and mean primary patencies were 2.8 ± 0.28 years (95% CI: 2.25–3.35) and 4.28 ± 0.40 years (95% CI: 3.51–5.05), respectively. The use of temporary SEMSs with 30-mm diameter proved to be a safe and effective approach for managing achalasia with a long-term satisfactory clinical remission rate.
- Open Access
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 16 (4) , 366-371
Optimization of contrast agents for small intestine computed tomography enteroclysis
目的: 评价何种对比剂在小肠CT造影时能充分充盈扩张肠管、不易形成伪影, 在显示小肠肠腔、肠壁方面最佳. 方法: 8条健康成年毕格犬麻醉后, 插管至十二指肠屈氏韧带以下, 静脉注射654-2, 经导管注入不同的对比剂: 纯水、纯牛奶、10 mL/L泛影葡胺后行MSCT扫描, 平扫结束后行增强扫描. 通过横断面及多平面重建, 测量肠腔宽度、肠壁厚度, 对各组测量及评价结果进行统计学分析. 同时测量平扫、增强后20 s、30 s、40 s、50 s 时肠壁的CT值, 测量计算肠腔与肠壁对比程度最好时, 肠腔与肠壁密度的CT值差值范围. 结果: 在肠腔宽度的比较上, 纯牛奶组与纯水组、泛影葡胺组的差异有统计学意义(F = 28.115, P结论: 纯牛奶是较理想的小肠CT造影对比剂, 能够充分充盈扩张肠腔, 同时能够较好的显示肠腔、肠壁的情况.
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 16 (4) , 366-371
Open AccessOptimization of contrast agents for small intestine computed tomography enteroclysis
目的: 评价何种对比剂在小肠CT造影时能充分充盈扩张肠管、不易形成伪影, 在显示小肠肠腔、肠壁方面最佳. 方法: 8条健康成年毕格犬麻醉后, 插管至十二指肠屈氏韧带以下, 静脉注射654-2, 经导管注入不同的对比剂: 纯水、纯牛奶、10 mL/L泛影葡胺后行MSCT扫描, 平扫结束后行增强扫描. 通过横断面及多平面重建, 测量肠腔宽度、肠壁厚度, 对各组测量及评价结果进行统计学分析. 同时测量平扫、增强后20 s、30 s、40 s、50 s 时肠壁的CT值, 测量计算肠腔与肠壁对比程度最好时, 肠腔与肠壁密度的CT值差值范围. 结果: 在肠腔宽度的比较上, 纯牛奶组与纯水组、泛影葡胺组的差异有统计学意义(F = 28.115, P结论: 纯牛奶是较理想的小肠CT造影对比剂, 能够充分充盈扩张肠腔, 同时能够较好的显示肠腔、肠壁的情况.
- Open Access
- 1 January 2004
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (2) , 284-286
Complications of stent placement for benign stricture of gastrointestinal tract
AIM: To observe the frequent complications of stent placement for stricture of the gastrointestinal tract and to find proper treatment. METHODS: A total number of 140 stents were inserted in 138 patients with benign stricture of the gastrointestinal tract. The procedure was completed under fluoroscopy in all of the patients. RESULTS: Stents were successfully placed in all the 138 patients. Pains occurred in 23 patients (16.7%), slight or dull pains were found in 21 patients and severe chest pain in 2 respectively. For the former type of pain, the patients received only analgesia or even no treatment, while peridural anesthesics was conducted for the latter condition. Reflux occurred in 16 of these patients (11.6%) after stent placement. It was managed by common antireflux procedures. Gastrointestinal bleeding occurred in 13 patients (9.4%), and was treated by hemostat. Restenosis of the gastrointestinal tract occurred in 8 patients (5.8%), and was apparently associated with hyperplasia of granulation tissue. In 2 patients, the second stent was placed under X-ray guidance. The granulation tissue was removed by cauterization through hot-node therapy under gastroscope guidance in 3 patients, and surgical reconstruction was performed in another 3 patients. Stent migration occurred in 5 patients (3.6%), and were extracted with the aid of a gastroscope. Food-bolus obstruction was encountered in 2 patients (1.4%) and was treated by endoscope removal. No perforation occurred in all patients. CONCLUSION: Frequent complications after stent placement for benign stricture of the gastrointestinal tract include pain, reflux, bleeding, restenosis, stent migration and food-bolus obstruction. They can be treated by drugs, the second stent placement or gastroscopic procedures depend on the specific condition.
- 1 January 2004
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (2) , 284-286
Open AccessComplications of stent placement for benign stricture of gastrointestinal tract
AIM: To observe the frequent complications of stent placement for stricture of the gastrointestinal tract and to find proper treatment. METHODS: A total number of 140 stents were inserted in 138 patients with benign stricture of the gastrointestinal tract. The procedure was completed under fluoroscopy in all of the patients. RESULTS: Stents were successfully placed in all the 138 patients. Pains occurred in 23 patients (16.7%), slight or dull pains were found in 21 patients and severe chest pain in 2 respectively. For the former type of pain, the patients received only analgesia or even no treatment, while peridural anesthesics was conducted for the latter condition. Reflux occurred in 16 of these patients (11.6%) after stent placement. It was managed by common antireflux procedures. Gastrointestinal bleeding occurred in 13 patients (9.4%), and was treated by hemostat. Restenosis of the gastrointestinal tract occurred in 8 patients (5.8%), and was apparently associated with hyperplasia of granulation tissue. In 2 patients, the second stent was placed under X-ray guidance. The granulation tissue was removed by cauterization through hot-node therapy under gastroscope guidance in 3 patients, and surgical reconstruction was performed in another 3 patients. Stent migration occurred in 5 patients (3.6%), and were extracted with the aid of a gastroscope. Food-bolus obstruction was encountered in 2 patients (1.4%) and was treated by endoscope removal. No perforation occurred in all patients. CONCLUSION: Frequent complications after stent placement for benign stricture of the gastrointestinal tract include pain, reflux, bleeding, restenosis, stent migration and food-bolus obstruction. They can be treated by drugs, the second stent placement or gastroscopic procedures depend on the specific condition.
- Open Access
- 1 January 2004
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (3) , 410-414
Comparative observation on different intervention procedures in benign stricture of gastrointestinal tract
Comparative observation on different intervention procedures in benign stricture of gastrointestinal tract
- 1 January 2004
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (3) , 410-414
Open AccessComparative observation on different intervention procedures in benign stricture of gastrointestinal tract
Comparative observation on different intervention procedures in benign stricture of gastrointestinal tract
- Open Access
- 1 January 2003
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 9 (10) , 2370-2373
Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up
Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up
- 1 January 2003
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 9 (10) , 2370-2373
Open AccessSelection and evaluation of three interventional procedures for achalasia based on long-term follow-up
Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up